MedPath

Role of a natural hormone supplement in improving pregnancy rate.

Phase 4
Conditions
Health Condition 1: N972- Female infertility of uterine origin
Registration Number
CTRI/2020/06/025918
Lead Sponsor
CRAFT Hospital and Research Centre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

INCLUSION CRITERIA

1.Women with age more than or equal to 35 years Or

2.women with AMH value less than 1.1 ng/ml or AFC less than 5 to 7

Whose serum testosterone less than 0.2 ng/ml

Exclusion Criteria

EXCLUSION CRITERIA

Women with PCOS.

Women with serum Testosterone �0.2 ng/ml

women with BMI more than 30kg/mt2

Women with Congenital and untreated or acquired uterine abnormality.

Women with Untreated hydrosalpinx.

Women with Thrombophilia.

Women with uncontrolled endocrine and heamatological dysfunction.

PGTA embryos

Those planning embryo transfer as per endometrial receptivity ERA

Thin endometrium less than 8mm in index cycle.

severe male factor infertility.

Difficult embryo transfer.

Cases where only poor quality embryos are available.

Couple with genetic and chromosomal abnormality

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Ongoing pregnancy rate or Live birth rateTimepoint: After 20 weeks
Secondary Outcome Measures
NameTimeMethod
b-HCG positive rate ,clinical pregnancy rate , miscarriage rate.Timepoint: 6 weeks, 20 weeks
© Copyright 2025. All Rights Reserved by MedPath